|
Market Closed -
CBOE
20:59:51 09/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 84.08 USD | -0.42% |
|
-1.53% | +26.68% |
| 10-07 | Evercore ISI Adjusts Price Target on DexCom to $110 From $90 | MT |
| 10-01 | RBC Raises Price Target on DexCom to $105 From $90, Keeps Outperform Rating | MT |
Company Valuation: DexCom, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 52,042 | 43,740 | 47,945 | 30,377 | 25,885 | 31,740 | - | - |
| Change | - | -15.95% | 9.61% | -36.64% | -14.79% | 22.62% | - | - |
| Enterprise Value (EV) 1 | 52,692 | 45,068 | 49,813 | 31,073 | 26,209 | 30,979 | 30,678 | 29,863 |
| Change | - | -14.47% | 10.53% | -37.62% | -15.65% | 18.2% | -0.97% | -2.66% |
| P/E | 346x | 138x | 95.5x | 54.8x | 31.8x | 33.8x | 28.5x | 23.6x |
| PBR | 23.1x | 20.5x | 23.1x | 15.1x | 9.3x | 11.2x | 9.31x | 7.16x |
| PEG | - | 1x | 1.6x | 5.94x | 0.7x | 1.8x | 1.5x | 1.1x |
| Capitalization / Revenue | 21.3x | 15x | 13.2x | 7.53x | 5.55x | 6.07x | 5.47x | 4.91x |
| EV / Revenue | 21.5x | 15.5x | 13.8x | 7.7x | 5.62x | 5.92x | 5.29x | 4.62x |
| EV / EBITDA | 111x | 60x | 49.1x | 28.1x | 19.4x | 18.6x | 16x | 13.5x |
| EV / EBIT | 142x | 92.9x | 69.3x | 41x | 27x | 24.8x | 21.2x | 17.4x |
| EV / FCF | 989x | 148x | 97.3x | 49.3x | 24.3x | 30.3x | 25.1x | 20.3x |
| FCF Yield | 0.1% | 0.68% | 1.03% | 2.03% | 4.11% | 3.3% | 3.98% | 4.92% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 0.3875 | 0.82 | 1.3 | 1.42 | 2.09 | 2.489 | 2.952 | 3.562 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,448 | 2,910 | 3,622 | 4,033 | 4,662 | 5,230 | 5,800 | 6,461 |
| EBITDA 1 | 472.7 | 751.6 | 1,014 | 1,105 | 1,349 | 1,667 | 1,920 | 2,207 |
| EBIT 1 | 370.7 | 485.1 | 718.6 | 757.1 | 969.3 | 1,248 | 1,446 | 1,719 |
| Net income 1 | 154.7 | 341.2 | 541.5 | 576.2 | 836.3 | 974.4 | 1,149 | 1,409 |
| Net Debt 1 | 650.1 | 1,328 | 1,868 | 695.9 | 323.2 | -761.1 | -1,061 | -1,877 |
| Reference price 2 | 134.24 | 113.24 | 124.09 | 77.77 | 66.37 | 84.11 | 84.11 | 84.11 |
| Nbr of stocks (in thousands) | 387,688 | 386,258 | 386,374 | 390,595 | 390,016 | 377,361 | - | - |
| Announcement Date | 10/02/22 | 09/02/23 | 08/02/24 | 13/02/25 | 12/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 29.16x | 3.91x | 15.12x | 2.58% | 172B | |
| 18.92x | 3.45x | 12.33x | 3.18% | 113B | |
| 21.59x | 4.24x | 14.82x | 1.3% | 106B | |
| 25.92x | 2.55x | 10.24x | 2.77% | 75.31B | |
| 17.73x | 0.21x | 12.94x | 0.73% | 61.8B | |
| 30.68x | 7.58x | 19.64x | 1.3% | 52.93B | |
| 35.41x | 3.42x | 11.72x | 2.14% | 50.05B | |
| 35.08x | 8.72x | 24.53x | -.--% | 40.81B | |
| 33.8x | 5.92x | 18.59x | -.--% | 31.74B | |
| Average | 27.59x | 4.44x | 15.55x | 1.56% | 78.28B | |
| Weighted average by Cap. | 26.13x | 4.03x | 14.71x | 1.95% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- DXCM Stock
- DXCM Stock
- Valuation DexCom, Inc.
Select your edition
All financial news and data tailored to specific country editions
